Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Christina Ha
Conference Coverage
Christina Ha, MD, on Diagnosis and Treatment of Stricturing Crohn Disease
05/19/2023
Dr Ha, from Mayo Clinic-Arizona, review the steps to properly diagnose stricturing Crohn disease and considerations in choosing and positioning therapies.
Dr Ha, from Mayo Clinic-Arizona, review the steps to properly diagnose stricturing Crohn disease and considerations in choosing and positioning therapies.
Dr Ha, from Mayo Clinic-Arizona,...
05/19/2023
Advances in Inflammatory Bowel Disease Network
Neil Hyman
Conference Coverage
Neil Hyman, MD, on Surgery as First-Line Therapy for Penetrating Crohn Disease
05/16/2023
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery...
05/16/2023
Advances in Inflammatory Bowel Disease Network
Michael Kappelman
Conference Coverage
Michael Kappelman, MD, on Combination Therapy With Anti-TNFs and Methotrexate in Pediatric Patients With IBD
05/09/2023
Dr Kappelman reviews the results of the COMBINE trial, in which the efficacy of combined therapy using antitumor necrosis factor therapies with low-dose methotrexate was compared to anti-TNF monotherapy in pediatric patients with inflammatory...
Dr Kappelman reviews the results of the COMBINE trial, in which the efficacy of combined therapy using antitumor necrosis factor therapies with low-dose methotrexate was compared to anti-TNF monotherapy in pediatric patients with inflammatory...
Dr Kappelman reviews the results...
05/09/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

David Rubin
Conference Coverage
David Rubin, MD, on Advancing Therapies and the Field of IBD Care
05/08/2023
Dr Rubin discusses his address from Digestive Disease Week 2023 in which he looks to the future of inflammatory disease therapy and advances in the field that include combination therapy, head-to-head drug trials, new therapies and more that...
Dr Rubin discusses his address from Digestive Disease Week 2023 in which he looks to the future of inflammatory disease therapy and advances in the field that include combination therapy, head-to-head drug trials, new therapies and more that...
Dr Rubin discusses his address...
05/08/2023
Advances in Inflammatory Bowel Disease Network
Gil Melmed
Conference Coverage
Gil Y. Melmed, MD, on Translating Evidence Into Quality for Patients With IBD
05/06/2023
Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, reviewed how to implement successful, practical quality improvements to the practice of gastroenterology to optimize outcomes among patients with inflammatory bowel disease.
Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, reviewed how to implement successful, practical quality improvements to the practice of gastroenterology to optimize outcomes among patients with inflammatory bowel disease.
Dr Melmed, from Cedars-Sinai...
05/06/2023
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Video
Phillip Fleshner, MD, on Optimizing IBD Surgery
04/28/2023
At the April 30 virtual regional meeting of Advances in Inflammatory Bowel Diseases, Dr Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center, discussed key steps gastroenterologists can take to help ensure their patients...
At the April 30 virtual regional meeting of Advances in Inflammatory Bowel Diseases, Dr Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center, discussed key steps gastroenterologists can take to help ensure their patients...
At the April 30 virtual regional...
04/28/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Christina Ha
Video
Christina Ha, MD, on Biosimilars in IBD
04/03/2023
At the AIBD regional in Baltimore, Dr Ha explained how the introduction of biosimilars of tumor necrosis factor inhibitors and in the future, other biologics, can expand access to these essential medications for the treatment of inflammatory...
At the AIBD regional in Baltimore, Dr Ha explained how the introduction of biosimilars of tumor necrosis factor inhibitors and in the future, other biologics, can expand access to these essential medications for the treatment of inflammatory...
At the AIBD regional in...
04/03/2023
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on the Potential of Interleukin Inhibitors in IBD
04/03/2023
Dr Long discusses her presentation at the Advances in Inflammatory Bowel Diseases regional meeting in Baltimore on the use of interleukin-12/23 and -23 inhibitors in the treatment of IBD.
Dr Long discusses her presentation at the Advances in Inflammatory Bowel Diseases regional meeting in Baltimore on the use of interleukin-12/23 and -23 inhibitors in the treatment of IBD.
Dr Long discusses her...
04/03/2023
Advances in Inflammatory Bowel Disease Network
Ray Cross
Video
Raymond Cross, MD, on Harnessing the Utility of S1P Receptor Modulators to Optimize Patient Care in IBD
04/01/2023
Dr Cross, director of the IBD Program at the University of Maryland School of Medicine, discusses the key points from his presentation at the Advances in IBD regional meeting in Baltimore on using sphingosine 1-phosphate receptor modulators...
Dr Cross, director of the IBD Program at the University of Maryland School of Medicine, discusses the key points from his presentation at the Advances in IBD regional meeting in Baltimore on using sphingosine 1-phosphate receptor modulators...
Dr Cross, director of the IBD...
04/01/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Ray Cross
Video
Raymond Cross, MD, Welcomes You to the AIBD Regional in Baltimore
03/27/2023
Dr Cross, regional chair for the Advances in Inflammatory Bowel Disease, invites you to the in-person regional meeting in Baltimore March 31-April 1 -- and offers a discount on the registration fee!
Dr Cross, regional chair for the Advances in Inflammatory Bowel Disease, invites you to the in-person regional meeting in Baltimore March 31-April 1 -- and offers a discount on the registration fee!
Dr Cross, regional chair for the...
03/27/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Requires Warning Label Change for Thiopurines
08/13/2024
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare...
08/13/2024
Advances in Inflammatory Bowel Disease Network
News
MM-SES-CD and SES-CD Threshold Scores and Risk of Disease Progression
08/12/2024
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple...
08/12/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use